Rights and permissions
About this article
Cite this article
Cetuximab plus chemotherapy beneficial in stage IV NSCLC. Inpharma Wkly. 1520, 14 (2006). https://doi.org/10.2165/00128413-200615200-00030
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615200-00030